Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications
European Journal of Neuroscience · 2024
DOI: 10.1111/ejn.16312 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Osvaldo M Basmadjian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Farmacología Experimental de Córdoba (IFEC-CONICET), Departamento de Farmacología Otto Orsingher, Facultad de Ciencias Químicas, Univers…. Hauptthemen laut MEDLINE: Amphetamine, Dopamine, Corpus Striatum, Angiotensin II. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Foncyt BID PICT 2016 N°0403 y Secyt-UNC.
Abstract (Originalsprache)
Amphetamine (AMPH) exposure induces behavioural and neurochemical sensitization observed in rodents as hyperlocomotion and increased dopamine release in response to a subsequent dose. Brain Angiotensin II modulates dopaminergic neurotransmission through its AT 1 receptors (AT 1 ‐R), positively regulating striatal dopamine synthesis and release. This work aims to evaluate the AT 1 ‐R role in the development and maintenance of AMPH‐induced sensitization. Also, the AT 1 ‐R involvement in striatal dopamine reuptake was analysed. The sensitization protocol consisted of daily AMPH administration for 5 days and tested 21 days after withdrawal. An AT 1 ‐R antagonist, candesartan, was administered before or after AMPH exposure to evaluate the participation of AT 1 ‐R in the development and maintenance of sensitization, respectively. Sensitization was evaluated by locomotor activity and c‐Fos immunostaining. Changes in dopamine reuptake kinetics were evaluated 1 day after AT 1 ‐R blockade withdrawal treatment, with or without the addition of AMPH in vitro. The social interaction test was performed as another behavioural output. Repeated AMPH exposure induced behavioural and neurochemical sensitization, which was prevented and reversed by candesartan. The AT 1 ‐R blockade increased the dopamine reuptake kinetics. Neither the AMPH administration nor the AT 1 ‐R blockade altered the performance of social interaction. Our results highlight the AT 1 ‐R's crucial role in AMPH sensitization. The enhancement of dopamine reuptake kinetics induced by the AT 1 ‐R blockade might attenuate the neuroadaptive changes that lead to AMPH sensitization and its self‐perpetuation. Therefore, AT 1 ‐R is a prominent candidate as a target for pharmacological treatment of pathologies related to dopamine imbalance, including drug addiction and schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Farmacología Experimental de Córdoba (IFEC-CONICET), Departamento de Farmacología Otto Orsingher, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
- INFIQC-CONICET, Departamento de Fisicoquímica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
- Laboratorio de Neurofarmacología, (IIBYT-CONICET), Universidad Nacional de Córdoba, Córdoba, Argentina.
Förderung
- Foncyt BID PICT 2016 N°0403 y Secyt-UNC
Zitieren
APA
Basmadjian, O. M., Occhieppo, V. B., Montemerlo, A. E., Rivas, G. A., Rubianes, M. D., Baiardi, G., & Bregonzio, C. (2024). Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16312
Vancouver
Basmadjian OM, Occhieppo VB, Montemerlo AE, Rivas GA, Rubianes MD, Baiardi G, et al. Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16312
BibTeX
@article{Basmadjian2024,
author = {Basmadjian, Osvaldo M and Occhieppo, Victoria B and Montemerlo, Antonella E and Rivas, Gustavo A and Rubianes, María D and Baiardi, Gustavo and Bregonzio, Claudia},
title = {Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications},
journal = {European Journal of Neuroscience},
year = {2024},
doi = {10.1111/ejn.16312}
}
EUVIMED